The mouse aldolase A gene contains two closely-spaced alternate promoter/first exons. The more distal of the two, the M promoter, is muscle-specific while the 3' promoter, the H promoter, is expressed constitutively. Various segments from these promoter regions were linked to a reporter gene and used to transfect the myogenic cell line C2C12 and the hepatoma cell line BWTG3. A muscle-specific enhancer, MEN1, responsible for 80% of promoter M activity and containing 4 consensus MyoD binding sites was localized between -2578 to -2723 of the M promoter. Another musclespecific enhancer and a restrictive element, MEN2IMSE, were found in the interval -1100 to -350. The MSE restrictive element was found to prohibit inappropriate up-regulation of the M promoter by selectively sequestering it from H promoter elements in both myoblasts and myotubes. Among the H promoter elements was found an enhancer, HEN, situated between -533 and -200 which did not function in myotubes. These studies also show that H promoter elements can act synergistically with a non-specific element, MAE, located between -350 and -130 of the M cap site greatly stimulating M promoter transcription in all cell types when the MSE restrictive element was absent. Through the analysis of interactions between these elements and the aldolase A and HSV-TK promoters we showed that neither the enhancers nor the promoter proximal sequences by themselves contain adequate information to reproduce the native pattern of aldolase A promoter modulation. Rather, the sequestering of the M promoter by the MSE restrictive element and the relative positioning and context of promoters M and H appear critical to the regulated expression of aldolase A.
INTRODUCTION
Detailed dissections of many tissue-specific promoters have identified an extensive collection of cis-acting sequence elements capable of conferring cell-type-specificity upon their associated transcription units. The majority of these analyses has been made using single promoter systems. The occurrence of multiple promoters in eukaryotes is relatively rare, and when such EMBL accession no. X61484 transcriptional units are found, the promoters are usually separated by large distances (at least several kilobase pairs (kb)) insuring functional independence. However, when placed in close proximity, tandemly arranged overlapping transcription units often utilize alternate methods of gene regulation such as transcriptional interference (1) or promoter occlusion (2), promoter competition (3) and enhancer damping (4) . Few studies have addressed the interrelationships or the influences of one promoter element set upon another in such situations. The aldolase A gene represents a multiple promoter arrangement where as many as three separate promoters exist within 2 kb of one another with each being expressed in a distinct pattern, making it an excellent locus to define and observe these unique higher-order promoter interactions.
Aldolase A is one member of three (designated A, B, and C) highly tissue-specific, developmentally regulated glycolytic isoenzymes (5) . The aldolase A gene product is the most ubiquitously distributed aldolase isoenzyme and can be found in all tissues at some point during development. In the adult, the aldolase A protein is found in all cell types except in liver where aldolase B is the sole isoform. The aldolase A gene and cDNAs have been cloned from several vertebrate sources including mouse (6, 7) , rat (8) , and human (9, 10) . Analysis of the gene structure and its expression indicates the gene has multiple alternative start sites. In the human, there are three different promoter/optional first exon regions designated N, M, and H. We have previously shown that in the mouse only M and H promoter/first exons are transcriptionally active and are utilized in a developmentally regulated tissue-specific fashion (6) . A similar conclusion was also reached recently for the rat aldolase A gene (11) . The arrangement of the promoters and alternative exons M and H in the mouse is shown in Figure 1 . M is the more distal promoter, located 0.9 kb 5' to the H promoter. Transcription from either promoter leads to an mRNA product which differs only in its first exon.
The aldolase A H-promoter can be classified as a housekeeping promoter due to its non-specific pattern of expression which results in the appearance of H-specific mRNA in all aldolase A containing tissues during development. Conversely, the expression of the M promoter is highly restricted to muscle tissue. Several examples of cellular genes utilizing alternative promoters exist including Drosophila melanogaster alcohol dehydrogenase (12) , the tropomyosin gene family (13) , rat 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (14) , rat insulin-like growth factor 11 (15) , and myosin light chain 1/3 (16) , among others. However, very few alternative promoter genes have been found to include both a strong housekeeping promoter in conjunction with a tissue-specific promoter. In fact, we are aware of only four: Drosophila melanogaster tropomyosin II (Tm II) (17) , human porphobilinogen deaminase (18) , rat acetyl-CoA carboxylase (ACC) (19) and aldolase A. Furthermore, only aldolase A, acetyl-CoA carboxylase and tropomyosin II are arranged with a tissue-specific promoter residing upstream of a housekeeping promoter. Of these three, the aldolase A promoters are separated by less than one kb compared to 8.8 and 12.3 kb of ACC and Tm II, respectively, thereby increasing the likelihood of higher-order promoter interactions.
The expression of both promoters during myogenesis in C2C12 cells is similar to their expression in vivo within a specific developmental time frame. Therefore, in vitro studies using C2C12 cells can be directly related to in vivo myogenesis. Furthermore, the M promoter is induced de novo during myogenesis while the housekeeping promoter, H, is active before, during and after induction of the M promoter both in vivo and in vitro (20, 21) . Limited modulation of the expression from the H promoter in the presence of a robust activation of the distal M promoter supports the conclusion that promoter occlusion does not occur to any great extent. Taking the close proximity of the promoters into account, this pattern of expression requires some mechanism(s) to 1) render the M promoter inactive before appropriate induction, 2) allow it to be expressed in a myogenicspecific fashion and 3) allow for continued H promoter activity. We have investigated cis-acting elements which may be involved in such mechanisms and have identified one element which modulates H promoter expression and five elements which can modulate M promoter expression, among them, a uniquely selective constitutive restrictive element and an element coinciding with a 120 bp cluster of 5 consensus MyoD binding sites (22) .
In doing so, we have delineated sequences that are necessary and sufficient for both the autonomous and the muscle-specific expression of promoter M in the presence and absence of promoter H. Due to the interdependency and lack of a stringent promoter specificity of some of the elements that we have identified, the relative positioning and the existence of a promoter sequestering mechanism are crucial to proper promoter selection and modulation of aldolase A transcription.
MATERIALS AND METHODS

Construction of CAT fusion genes and generation of deletion mutants
The isolation and characterization of mouse aldolase A genomic clones has been described in detail (6) . To prepare a reportergene construct capable of reproducing aldolase A alternate promoter activity, a 7 kb contiguous genomic region composed of 5' flanking sequences (-5000 of M), all promoters/optional first exons, first introns and a portion of the 5' untranslated region of exon 2, was fused to the 5' untranslated leader of the chloramphenicol acetyltransferase gene. It was constructed in a two-step process entailing first the construction of an exon 2/CAT fusion receiving vector followed by the insertion of a 5' genomic fragment. A 500 base pair (bp) Hind III fragment from the genomic clone Syrinx Ex3. 1 was subcloned into pBS (Stratagene). This clone was digested with Pvu II and a 400 bp fragment was gel purified, redigested with Ban I and treated with mung bean nuclease. Then, the DNA was cleaved with Hind III and ligated to a promoterless CAT clone, BLCAT3 (23) , which was prepared by digestion with Xho I, treatment with mung bean nuclease, and redigestion with Hind III. The resultant construct, 78CAT, was sequenced to confirm that the various cloning procedures had correctly fused the 5' untranslated leader of exon 2 to the CAT reporter gene. A 7 kb Hind III fragment contiguous in the 5' direction to the 500 bp Hind III fragment used above was then subcloned from the genomic clone, Syrinx Ex3. 1, into 78CAT creating -5kWT. From this parent construct three sets of derivatives, based on the deletions of either the M promoter/exon, the H promoter/exon or the complete M intron (fused M exon directly to CAT), were prepared.
M promoter/exon deletions were made from -5kWT by complete digestion with Sac II followed by partial digestion with Nae I or Xho I, treatment with T4 DNA polymerase and religation to create A-130M/-533H and A-130M/-200H, respectively (see Figure 2A ).
H promoter/exon deletions were generated by digestion of -5kWT with Xho I or Nae I followed by religation. These clones, -SkAH and -5kNaelAH, maintain a functional M intron but have deletions beginning at -195 bp (Xho I) or -533 bp (Nae I) of exon H and end at 500 bp (Xho I) or 600 bp (Nae I) 3' of that exon respectively (see Figure 3) . To prepare 5' deletion clones -5kAH was linearized by digestion with Kpn I and partially digested with Xba I to liberate a 6.5 kb aldolase A-CAT casette which was then ligated into pBS previously digested with Xba I and Kpn I. The deletions -1. lkAH, -350AH and -130AH were generated from the Xba I/Kpn I subclone by Sal I cleavage followed by partial digestion with Acc I, Xba I or Sac II, respectively, and then treatment with T4 DNA polymerase and religation (see Figure 4B) .
The M intron deletion parent was prepared from 7KAH82CAT (6) , a -SkAH relative, which maintains an Xho I restriction site at the fusion point of aldolase A to BLCAT3 sequences. This construct was digested to completion with Xho I and partially digested with Bsp El and religated to form -5kM which is identical to -SkAH except that the internal H exon deletion has been enlarged removing all of the M intron except the 5' most 12 bp effectively fusing the M exon directly to the CAT 5' untranslated sequence. The clones -3.7kM, -2.2kM, -350M and -130M were generated by linearization of -5kM by cleavage with Hind III, partial digestion with the enzymes Xba I, Bsm I and Sac II, respectively, followed by treatment with T4 DNA polymerase and religation (see Figure 4A ). Additional deletions were created by the exonuclease Ll/mung bean nuclease method (24) using the Xba I/Kpn I subclone. These nested deletions were subcloned into -5kM in the Hind III/Sac II site of the vector to generate clones: -2907M, -2723M, -2578M, -2505M and -2437M (see Figure 4A) .
The herpes simplex virus (HSV) thymidine kinase (TK) promoter-driven CAT casette vector, BLCAT2 (22) , was used as a heterologous promoter test construct. The 7 kb Hind III fragment from -5kWT was cloned into the Xba I site of BLCAT2, in both orientations using the partial fill-in method to create compatible termini (25) . The resulting clones were digested to completion with Sac II and either Bam HI or Sal I to create the clones -Sk/ -13OMTK and -130/ -SkMTK respectively (see Figure 2B ). The clone -SkAH was digested to completion with Sst I and Nae I and a 330 bp fragment was gel purified and cloned into the 3' multi-cloning sites Sma I and Sst I of BLCAT2 to generate TK-533/-200H (see Figure 2A) . 
Cell transfections
The above constructs and SV2CAT (26) were purified by two cycles of isopycnic centrifugation in cesium chloride-ethidium bromide gradients and used to transfect BWTG3 (27) and C2C12 (28) CAT assays and data manipulation Cells were harvested by scraping and extracts were prepared by four cycles of freeze-thawing followed by heat treatment at 650C for 10 minutes and centrifugation. CAT assays were performed using the phase-extraction assay (30) . (33, 34) . The raw CPM data from each construct in a given experiment was normalized to the sum total CPM output of all constructs in that experiment. An experiment constitutes a particular subset of constructs all transfected and harvested simultaneously using the same passage of cells. In general, each CAT assay figure presented in this paper represents data obtained from the same experiment. This protocol corrected for inter-experiment transfection variation, represented by comparison of sum total CPM activities generated by a particular construct subset from different experiments, and eliminated the dependency upon the reproducibility of just one construct per experiment as the sole point of reference between experiments. Data normalized in this manner were used to generate means and standard deviations. Relative differences between cell types was next factored in by multiplying these values by the mean of the sum total CPM outputs generated by a particular construct subset from all experiments in a given cell type. This procedure allowed reconstitution of fold inductions between myoblasts and myotubes. Different subsets of constructs were related to one another through normalization to at least two common constructs between a given pair of subsets. The resultant activities plotted in this paper are shown relative to the myotube activity of construct -5kM for C2C12 cells and to -5kWT for BWTG3 cells both of which were arbitrarily given the value of 100.
RESULTS
H promoter mediated transcription is very strong and capable of muscle-specific induction in the absence of the M promoter To dissect how closely spaced non-specific and tissue-specific promoters might interact and react to a common environment, we investigated cis-acting elements within the 5 Figure 3 . The H enhancer domain acts in a cell independent and a promoter independent fashion. The attributes of this figure are the same as those of Figure 2 with the exception that all activities are shown relative to -5kWT (arbitrarily assigned a value of 100). mouse aldolase A gene. Different segments within the 5' region were fused to the bacterial chloramphenicol acetyltransferase gene. All constructs, except -5kWT, contained either promoter/exon M or H allowing direct assignment of CAT activity to a specific promoter. Each clone maintained appropriate splice sites for correct post-transcriptional splicing of the M-or H-specific exon to CAT mRNA.
As shown in Figure 2A , -5kWT is a powerful base construct providing a promoter activity 9-times stronger than the SV40 enhancer/promoter in both myoblasts and myotubes. To elucidate elements that could modulate the H promoter, deletions were made of -5kWT which removed the M exon and 5' portions of the H promoter. A deletion, A-130M/-533H, beginning at -130 of the M-start site and ending 3' at -533 of the H-start site removes the M exon/promoter without altering H promoter levels in myoblasts but produces a 2.5 to 3-fold induction in myotube activity indicating H promoter stimulation by musclespecific elements. Deletion of the 3' border to -200 of the H start site (A -130M/ -200H) reduces activity by 45 -55S% in both myoblasts and myotubes indicating removal of a strong nonspecific positive element.
We tested the ability of the interval defined by the two deletions, A -130M/ -533H and A -130M/ -200H (the region between -533 and -200), to influence the transcription of a heterologous upstream promoter by placing it 3' of an HSV-TK promoter-driven CAT casette emulating its position relative to the M promoter. This construct, TK-533/ -200H, produced an enhancement of 7-fold above basal level TK promoter activity (BLCAT2) in myoblasts and 2-fold in myotubes (Figure 2A) . Thus, this subfragment not only is capable of supplying a large proportion of H promoter activity, it can also enhance, in a nonmyotube-specific manner, the activity of a heterologous promoter from a downstream position. We designated this element HEN due to its location (H promoter) and activity (ENhancer). The HEN domain acts in a cell independent as well as a promoter independent fashion We investigated the cell specificity of the H and M promoters by transfection into BWTG3 cells, a mouse hepatoma cell line ( Figure 3 ). However, a more extensive deletion of the M promoter in the 3' direction from the Nae I to the Xho I site, A -130/ -200H, showed only 30% of the activity of the parent construct. The additional deletion removed the HEN domain (Nae I-Xho I) we previously identified (Figure 2A ). From these results we concluded that the HEN domain is capable of stimulating transcription from both M and H promoters in a cell independent fashion. Potent muscle-specific enhancer and regulatory elements are located 5' of the M promoter The experiments in Figure 2A suggested that muscle regulatory elements reside 5' of the M promoter. To verify this hypothesis, the common 5' distal segment spanning 3' at position -130 to -5000 of the M start site was inserted in either orientation 5' of an HSV-TK promoter-CAT cassette. The construct, -5k/-130MTK, demonstrated a strong myotube-specific enhancer activity of 18-times that of parental clone BLCAT2 and -130/ -5kMTK showed a 4-fold enhancement in the reverse orientation ( Figure 2B ). We compared this activity to that obtained from a construct containing the same 5' region (Hind HI-Sac II) but extended 3' to include the M promoter/exon fused directly to CAT thus replacing the TK promoter with the M promoter (-5kM Figure 4A ). The most significant reduction in activity (five-fold) occurred between -2723M and -2578M. The remote location and the high level of muscle-specific promoter stimulation are both characteristic and consistent with this sequence harboring a strong muscle-specific enhancer. Due to its remote location and activity we designated this domain MEN 1 (M promoter ENhancer L Figure 4C) . Deletion of the interval between -2.2kM and -350M caused alterations in both myoblast and myotube activities. The myotube activity was reduced 3-fold to 7% of -5kM while the myoblast activity increased 5-fold to a similar level. This demonstrates that in addition to deleting a myotube-specific positive element, a negative element was also removed allowing up-regulation of myoblast activity by downstream promoter elements. This negative element appears to be promoter specific and does not affect the H promoter or the heterologous TK promoter as shown by constructs A-130M/-533H, A-130M/-200H (Figure 2A) , -Sk/-130MTK, and -130/-SkMTK ( Figure 2B ). This apparent promoter specificity is unlikely to be an artefact due to a minimal distance requirement since the 3' border of the negative domain as defined by deletion -350M is greater than the distance of this same region with respect to the heterologouspromoter start sites in -Sk/ -130MTK and A -13GM/ -200H.
Furthermore, in the natural context, the expression pattern of the H promoter would suggest this negative activity cannot be exerted over long distances (at least 1.2 kb) upon heterologous promoters as expected of a silencer (35) . We designated this combination of positive and negative domains MEN2/MSE (M ENhancer 2/M Sequestering Element, Figure 4C) Figure 4C ). The construct -130M resembles a basal promoter with an output approximately one-half of that of the basal promoter TKCAT casette (BLCAT2 in Figure 2A ). In summary, there are at least 3 positive and one negative domains: two domains, MEN1 and MEN2, are myotube-specific and provide over 93% of the wild-type myotube activity; MAE is a nonspecific promoter-proximal element representing 5 % of myotube expression; and MSE is a muscle-restrictive element preventing inappropriate up-regulation of myoblast activity (see Figure 4C ). Figure 4B ), the downstream sequences including the 5' untranslated portion of exon 2 was added. In this segment sequences flanking the H promoter (-195 to +750) were deleted. The clones differed in the length of DNA 5' to the M promoter. Constructs -5kAH and -1. IAH had myotube activities similar to comparable -5kM constructs but showed a substantial increase in myoblast activities of approximately 6-9-fold ( Figure 4A and 4B ). This increase in myoblast activity must be due to the addition of enhancer elements 3' of the M promoter/exon. These elements marginally overcome the non-myotube-specific inhibitory activity associated with the M promoter 5'-flanking sequences. Clone -350AH showed a dramatic up-regulation of both myoblast and myotube activities to almost 17-fold higher than that of -350M ( Figure 4A ). This construct lacks the MSE negative domain necessary for muscle-specific restriction and as a result allows the demonstration that 3' intragenic elements can dramatically activate M promoter sequences found within -350 to up-regulate non-specifically M transcription to very high levels. The more 3' deletion, -130AH, gives about a two-fold reduction in myoblast activity similar to the -130M construct ( Figure 4A ), and an 8-fold decrease in myotubes. (20, 21) . In C2C12 myoblasts only the H promoter is active. When myoblasts are allowed to reach confluency and are switched to a mitogen deficient media, the process of myogenic differentiation into myotubes begins.
Promoter M activation can be detected within 24 hours of this alteration in culture conditions. Promoter M steady state mRNA levels constantly increase throughout the entire culture period constituting 10-30% of aldolase A mRNA in 2 to 3 days (time of harvest in transfection studies) to over 80% after 6 days of differentiation in extended cultures. Promoter H steady state mRNA levels undergo a decrease of approximately 2-fold during this same period. As shown in Figures 2A and 3 , a deletion, A-130M/-533H, beginning at -130 of the M-start site and ending 3' at -533 of the H-start site created a powerful promoter construct with an activity 8-times stronger than the SV40 enhancer/promoter in myoblasts, 17-times stronger in myotubes and 3-4 times stronger in hepatoma cells. The strength of this construct is remarkable and appears to be several times stronger in C2C12 cells than either 3-actin (36) or muscle creatine kinase (37) relative to SV2CAT. Extending the 3' deletion to -200 of the H start site (A -130M/ -200H) reduces activity by 45-55% in both myoblasts and myotubes and 65-75% in hepatoma cells indicating removal of a strong non-specific positive element which we designated HEN. Previously published studies involving the aldolase A promoter region have dealt only with the analysis of the H promoter. Those studies of the human (38, 39) and rat (40) aldolase A genes demonstrated that at least two separate positive regulatory domains existed. The strongest and most promoterdistal domain appears to be delineated by a 5' border at -311 (38) , and its 3' border at -262 (40) . This segment is homologous to the mouse sequence between -305 and -266 of the H start site. It has also been shown in the rat that this region can enhance H expression several fold in an orientation independent manner, and when deleted shows a 25-fold decrease in Hep G2 cells. The deletion causes an approximately three-fold decrease in the human promoter in Hep 3B cells. The positive acting region that we have delineated (-533 to -200) appears to be consistent with the previously defined most promoter-distal element. When the interval, -533 to -200, is placed downstream of BLCAT2 it can efficiently enhance the heterologous HSV-TK promoter in a non-myotube-specific manner (construct TK-533/-200H, Figure 2A) . Therefore, the non-myotube-specific enhancer activity of the most distal H enhancer domain has the ability to influence a 5' heterologous promoter over 1.8 kb away. The position of this element suggests that the M promoter should be equally susceptible to such enhancer-driven stimulation in myoblasts. When a construct missing the H promoter but containing the M promoter and 5' flanking sequence (-SkAH) was transfected into hepatoma cells a small but detectable amount of activity was recorded (Figure 3 ). This activity was abolished when the deletion was extended to include the HEN domain described above (-SkNaeIAH). These constructs showed that the M promoter could respond to downstream enhancer activity and suggests that in its natural context the M promoter might be susceptible to enhancement from the HEN domain. However the M promoter is not active in myoblasts in vivo, therefore some mechanism must prevent the interaction of the HEN domain with the M promoter. Additionally by removal of the downstream promoter in these constructs and others in this study, the mechanism of promoter competition as defined by Winston et al. (3) can be excluded as the chief regulator of promoter M activity.
In addition to their high activity in myoblasts, both constructs A-130M/-533H and A-130M/-200H demonstrated a 2.5 to 3-fold myotube-specific induction over that displayed by -SkWT and inconsistent with normal H promoter modulation which undergoes a decrease in activity during myogenesis in vivo and in vitro (Figure 2A ) (21) . Therefore some muscle-specific elements must be stimulating the H promoter inappropriately in these constructs.-The origin of such muscle-specific activity affecting promoter H has not been determined but it is possible that the muscle-specific enhancer elements, MEN1 and MEN2, we have delineated 5' of promoter M (see Figure 4A) In a search for additional elements which may be capable of interacting over long distances with either promoters M or H, the upstream region of promoter M was examined. Placing a S kb interval which included all available S'-flanking sequence from -130 to -5000 of the M start site upstream of BLCAT2 in both orientations produced the constructs -Sk/ -13OMTK and -130/ -SkMTK ( Figure 2B ). The forward orientation produced a large (18-fold) myotube-specific induction of the HSV-TK promoter and in the reverse orientation a four-fold induction confirming the existence of a powerful muscle-specific enhancer in this sequence. The orientation preference of this region may be similar to that observed for the embryonic myosin heavy chain gene (42) or maybe a result of the inclusion of some short range promoter elements located near the -130 position. Additionally, a promoter preference for the M promoter is evident upon comparison of the TK promoter constructs to -5kM. Deletion analysis was performed upon -5kM to delineate these enhancer elements. The construct -5kM and some of its derivatives displays an induction of 50 to 75 fold under our culture conditions. This degree of muscle-specific induction in a transient transfection experiment is equalled by only a few other muscle-specific genes such as muscle creatine kinase (43) and troponin I (44) .
The very strong muscle-specific element MEN was localized between -2723 and -2578 of the M start site. This element accounts for over 80% of -SkM's activity and is the strongest tissue-specific element in the aldolase A locus. Sequence analysis of this region revealed the presence of S consensus MyoD binding sites situated in less than 120 bp with 4 of these tightly clustered in a 60 bp domain ( Figure 5 ). The only other naturally occuring enhancer we are aware of which equals this density of MyoD sites is that of myosin light chain 1/3 which contains 4 sites (45) . MyoD has been shown to bind cooperatively to a target enhancer and requires occupancy of at least two sites for transcriptional activation to occur. It is also known that 3 or 4 MyoD sites can stimulate transcription more than 2 sites alone thus it is reasonable to speculate that such redundancy in the aldolase muscle enhancer removing one MyoD site did not alter the activity significantly. Deletion -2578M removes the remaining 4 MyoD sites and reduced activity by over five-fold. Additional putative musclespecific cis-acting elements also existed in the domain delimited by -2723M and -2578M. Several motifs were similar to those found in the enhancer domains of mouse muscle creatine kinase (47) , rat myosin light chain 1/3 (48), the a and / subunits of the chicken acetylcholine receptor (49) , and quail troponin 1 (50) . Muscle creatine kinase enhancer elements E4 and El overlap aldolase A putative MyoD binding sites 1 and 5 (numbered 5 This sequence is crucial to SV40 enhancer function and is involved in the binding of both Ap3 and C/EBP (53, 44) . A 9 bp site contains similarities to both MCAT (55) and ACRE (acetylcholine receptor) (56) factor binding sites with a 1 bp mismatch each. Additional sites able to bind NFe (MHCembBSe) (57) and E2BP (MCK-E2) (51) exist at the 3' and 5' most borders, respectively. The high sequence similarity and close association of 4 of these MyoD sites with other muscle-specific cis-acting motifs suggests these sites are authentic and possibly interact with other transcription factors that may bind these adjacent motifs.
An additional muscle-specific element was localized between -1 100 and -350 of the M start site (see Figure 4 ). This element, MEN2, accounts for over 13% of -5kM activity and may also be an enhancer since it has activity greater than that of SV2CAT. The MEN1 and MEN2 elements are the only muscle-specific elements found at the aldolase A locus and together account for over 93% of the output of -5kM.
Deletion analysis also uncovered the negative element, MSE, in the interval -1100 to -350 of the M start site as evident by the construct -350M showing an abrupt increase of activity in myoblasts ( Figure 4A ). The expression pattem of the endogenous H-promoter suggests that this negative activity cannot be exerted over long distances upon heterologous promoters such as exhibited by silencers. Mechanistically, MSE acts as the predominate regulator of downstream sequences which mediate promoter up-regulation but does not inhibit activation by M enhancer elements (MENI and MEN2) located 5' of the M promoter. Thus MSE selectively sequesters promoter M from non-specific stimulatory activities indicating that it does not directly inhibit the binding of the initiation complex to the TATA box or to the start site of the M promoter. We believe MSE primarily interacts with another nearby domain which, when present, acts as a node through which all enhancer activities must be channeled in the activation of promoter M. A good candidate for such a domain is the non-specific positive element, MAE, that was localized between -350 and -130, just upstream of the minimal M promoter. The MAE domain can act cooperatively with sequences found near the H promoter to activate dramatically M expression non-specifically in the absence of the MSE ( Figure 4B, constructs -350AH and -130AH ). This synergism may explain its great strength (46) . The deletion in -2723M
can drive the M promoter to levels similar to those observed in -5kM and -5kAH. When the MAE domain is deleted in -130AH and -130M the remaining sequences behave as a minimal promoter as judged by comparison to the heterologous promoter construct TK-533/ -200H and BLCAT2. Two pieces of evidence suggests the MSE negative activity is present in both myoblasts and myotubes. First, the construct -5kAH does not demonstrate any cumulative effect of the addition of 3' intragenic elements to the activity of the M promoter/enhancer of construct -5kM in myotubes. Second, by deleting the restrictive element (compare constructs -1. LkAH and -350AH, Figure 4B ) a strong upsurge in myotube activity occurs suggesting that a negative activity is counteracting the positive effect of sequences residing 3' of the promoter in both myotubes and myoblasts. Within our experimental system, which parallels early in vivo development, it is apparent that the musclerestrictive activity is maintained in both myoblasts and myotubes essentially sequestering the M promoter from the effects of the H promoter at all times. In this manner, the MSE domain appears to be the pivotal domain in the maintenance of muscle specificity by the aldolase A M promoter. It is an attractive possibility that MSE activity may dissipate in muscle tissue as the newborn matures into an adult allowing the recruitment of H promoter elements to further enhance M promoter output thus accounting for the observed increase in M transcription during this final developmental stage in vivo (21) . Such a model can best be tested in transgenic animals.
Alternate explanations can be made for data obtained from some aldolase intron containing constructs in Figures 3 and 4 . First, the deletions created by XhoI or NaeI of M intronic sequences in -5kAH derivatives or -5kNaeIAH could effect the processing efficiency of M intervening sequences resulting in an alteration of gene expression. Such an occurrence would appear unlikely since the intronic sequences deleted are 300-600 bp away from either splice junction, leaving intact all sequences considered necessary for the proper processing of the intron. Second, the addition of functional introns into 5' untranslated regions of reporter constructs can stimulate gene expression (59) . The equal myotube expression of parental constructs -5kM and -5kAH in Figure 4A and 4B does not appear to support this conclusion. However a 6 to 9-fold increase in myoblast activity does correlate with the inclusion of an intron suggesting the possibility of a tissue-specific contribution through intron processing rather than the sole attribution of the increase to intronic cis-acting transcriptional elements. The impact of 5' aldolase A intron processing upon aldolase gene expression cannot be adequately assessed by these results and will have to await a more directed line of experimentation. Figure 6 the H promoter is masked or shielded from the full effect of M enhancers by M transcriptional interference or M enhancer damping in this model. In summary, we have identified and characterized the primary regulatory domains of the mouse aldolase A locus. It was determined that both aldolase A promoters exist within the overlapping zones of at least two different enhancers, each with a different tissue specificity. In an effort to understand how each promoter reacts and interacts within this environment we discovered that the M promoter is selectively sequestered from the influence of the H promoter/enhancer domains in both myoblast and myotubes by a restrictive domain located in the M promoter. By sequestering the M promoter, muscle-specific elements become the primary determinants in the switching on of the M promoter. Additionally, we have presented evidence that promoter M sequences may be required for the proper regulation of promoter H activity. We are currently examining the muscle restrictive and enhancer elements in detail.
